Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 15,008 shares at $117.60 ($1.7M) on 2021-01-08, disclosed to the SEC on 2021-01-12.
Open-market sale of $1.7M FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.76 | 151 | $17K | 1.0% |
| 2 | $115.80 | 872 | $101K | 5.9% |
| 3 | $115.80 | 872 | $101K | 5.9% |
| 4 | $117.15 | 2,451 | $287K | 16.7% |
| 5 | $117.15 | 2,451 | $287K | 16.7% |
| 6 | $117.60 | 2,755 |
| $324K |
| 18.8% |
| 7 | $109.65 | 871 | $96K | 5.5% |
| 8 | $109.65 | 871 | $96K | 5.5% |
| 9 | $110.76 | 1,050 | $116K | 6.8% |
| 10 | $111.62 | 1,332 | $149K | 8.6% |
| 11 | $111.62 | 1,332 | $149K | 8.6% |
| Total | $114.75 avg | 15,008 | $1.7M | 100% |
| Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |
| FATE | SELL | 2020-01-02 | $973K | — | Filing → |